Jaudat Mahmood
Interventional Pain Medicine · Kent, OHNPI 1295154649
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. SPR Therapeutics, Inc accounts for 93.2% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $42,261, more than ten times the $3,163 reported in 2019. Among interventional pain medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $399.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$90K
- Nevro Corp.$4K
- Abbott$745
- Averitas Pharma Inc.$455
- Medtronic$267
- Vertos Medical, Inc.$235
- plus $1K from 17 others
What the payments were for
- Consulting fees$56,90959%
- Travel & lodging$31,02832%
- Food & beverage$8,7759%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 123 | $90,132 |
| Nevro Corp. | 32 | $3,658 |
| Abbott | 14 | $745 |
| Averitas Pharma Inc. | 16 | $455 |
| Medtronic | 13 | $267 |
| Vertos Medical, Inc. | 4 | $235 |
| Boston Scientific | 2 | $134 |
| Painteq LLC | 4 | $131 |
| Stryker | 1 | $131 |
| Collegium Pharmaceutical, Inc. | 6 | $125 |
| Insmed, Inc. | 1 | $125 |
| Nalu Medical, Inc. | 3 | $114 |
| Si-bone, Inc. | 4 | $92 |
| Biodelivery Sciences International, Inc. | 4 | $66 |
| Vertex | 3 | $63 |
| Relievant Medsystems, Inc. | 2 | $59 |
| Pacira Pharmaceuticals Incorporated | 2 | $42 |
| Curonix LLC | 2 | $38 |
| Johnson & Johnson | 1 | $31 |
| Pacira Therapeutics, Inc. | 2 | $24 |
| Hydrocision, Inc. | 1 | $16 |
| Saluda Medical Americas, Inc. | 1 | $15 |
| International Rehabilitative Sciences, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$87,958
- Senza Spinal Cord Stimulation System$2,973
- PROCLAIM$408
- mild Device Kit$135
- SPINEJACK$131
- Arikayce$125
- INFINION$118
- Qutenza$108
How this compares
$96,712 in reported general payments places this provider in the 95th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,352 | $31,517 |
| BelbucaBuprenorphine Hcl | 22 | $16,374 |
| Xtampza ErOxycodone Myristate | 24 | $10,446 |
| Hysingla ErHydrocodone Bitartrate | 15 | $9,144 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 181 | $4,135 |
| Buprenorphine | 12 | $2,363 |
| Fentanyl | 11 | $2,303 |
| Morphine Sulfate ErMorphine Sulfate | 70 | $1,858 |
| Pregabalin | 32 | $1,245 |
| Gabapentin | 92 | $1,127 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 38 | $663 |
| Methocarbamol | 35 | $469 |
| Tizanidine Hcl | 36 | $466 |
| Oxycodone Hcl | 19 | $434 |
| Cyclobenzaprine Hcl | 36 | $405 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $125 | $26,82046 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 67 interventional pain medicine providers in Ohio.
Other interventional pain medicine in Kent
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
- David WalegaColumbus$37K
- Ronald LinehanLancaster$26K
- Vivekanand ManochaMason$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.